Buske C - Search Results

1

The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcome.

Buske C, Hoster E, Dreyling M, Hasford J, Unterhalt M, Hiddemann W. Buske C, et al. Blood. 2006 Sep 1;108(5):1504-8. doi: 10.1182/blood-2006-01-013367. Epub 2006 May 11. Blood. 2006. PMID: 16690968 Free article. Clinical Trial.

2

Proliferation of human leukemic pre-B cells induced by human bone marrow stromal cells and murine fibroblasts.

Buske C, Hiddemann W, Wörmann B. Buske C, et al. Cell Biol Int. 1994 Nov;18(11):1049-58. doi: 10.1006/cbir.1994.1028. Cell Biol Int. 1994. PMID: 7894389

3

TGF-beta inhibits growth and induces apoptosis in leukemic B cell precursors.

Buske C, Becker D, Feuring-Buske M, Hannig H, Wulf G, Schäfer C, Hiddemann W, Wörmann B. Buske C, et al. Leukemia. 1997 Mar;11(3):386-92. doi: 10.1038/sj.leu.2400586. Leukemia. 1997. PMID: 9067578

4

Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand.

Buske C, Gogowski G, Schreiber K, Rave-Fränk M, Hiddemann W, Wörmann B. Buske C, et al. Exp Hematol. 1997 Apr;25(4):329-37. Exp Hematol. 1997. PMID: 9131008

5

Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer.

Wulf GG, Jürgens B, Liersch T, Gatzemeier W, Rauschecker H, Buske C, Hüfner M, Hiddemann W, Wörmann B. Wulf GG, et al. Among authors: buske c. J Cancer Res Clin Oncol. 1997;123(9):514-21. doi: 10.1007/BF01192207. J Cancer Res Clin Oncol. 1997. PMID: 9341902

6

Treatment of follicular follicle centre lymphomas: current status and future perspectives.

Hiddemann W, Unterhalt M, Buske C, Sack H. Hiddemann W, et al. Among authors: buske c. J Intern Med Suppl. 1997;740:55-62. J Intern Med Suppl. 1997. PMID: 9350184 Review.

7

In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand.

Buske C, Twiling A, Gogowski G, Schreiber K, Feuring-Buske M, Wulf GG, Hiddemann W, Wörmann B. Buske C, et al. Leukemia. 1997 Nov;11(11):1862-7. doi: 10.1038/sj.leu.2400822. Leukemia. 1997. PMID: 9369419

8

[Systemic therapy of low malignancy non-Hodgkin lymphomas].

Wörmann B, Buske C, Hiddemann W. Wörmann B, et al. Among authors: buske c. Praxis (Bern 1994). 1998 Jun 3;87(23):806-11. Praxis (Bern 1994). 1998. PMID: 9654987 Review. German.

9

Elevated serum level of soluble CD23 precedes development of B-non-Hodgkin's lymphoma in SIV-infected Rhesus monkeys.

Hannig H, Buske C, Mätz-Rensing K, Hunsmann G, Hiddemann W, Bodemer W. Hannig H, et al. Among authors: buske c. Int J Cancer. 1998 Aug 31;77(5):734-40. doi: 10.1002/(sici)1097-0215(19980831)77:5<734::aid-ijc12>3.0.co;2-1. Int J Cancer. 1998. PMID: 9688307 Free article.

10

TGF-beta and its receptor complex in leukemic B-cell precursors.

Buske C, Becker D, Feuring-Buske M, Hannig H, Griesinger F, Hiddemann W, Wörmann B. Buske C, et al. Exp Hematol. 1998 Nov;26(12):1155-61. Exp Hematol. 1998. PMID: 9808055

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

276 results

Search Page